Skip to content
Search

Latest Stories

India stick with Shaw to open batting; Saha to keep wicket

India have kept faith with opener Prithvi Shaw while opting for Wriddhiman Saha ahead of Rishabh Pant as wicketkeeper for the opening day-night Test against Australia in Adelaide starting on Thursday (17).

Selectors also confirmed Umesh Yadav as the third seamer alongside Mohammed Shami and Jasprit Bumrah in the absence of the injured Ishant Sharma, while Ravi Ashwin won the race to be their frontline spinner ahead of Kuldeep Yadav.


The flamboyant Shaw was under pressure from another young talent -- Shubman Gill, also 21 -- to open the innings alongside Mayank Agarwal after just one decent knock in four warm-up innings.

But he will take the field for his fifth cap on Thursday while Gill continues his wait to earn a first.

"Shubman has not gotten opportunities at this level yet in Test cricket," skipper Virat Kohli said shortly before the team was announced.

"As and when he gets an opportunity, it would be interesting to see how he goes because he is a very confident young man.

"Prithvi has performed at the Test level, but he would be playing in Australia for the first time. I think it is very exciting to see his progress as well."

The dogged and experienced Cheteshwar Pujara will come in at number three, followed by Kohli in his only Test of the tour before heading home for the birth of his first child.

Vice-captain Ajinkya Rahane and Hanuma Vihari, who both scored centuries in warm-up games against Australia A, round out the middle order.

Pant, an explosive batsman who became a viral sensation on India's last tour of Australia with his banter behind the stumps, also stroked a quickfire ton against Australia A, but he was surprisingly overlooked in favour of Saha.

India won their maiden series 2-1 in Australia in 2018-19 -- including victory in Adelaide, although that game was not a day-night Test.

India: Mayank Agarwal, Prithvi Shaw, Cheteshwar Pujara, Virat Kohli (capt), Ajinkya Rahane, Hanuma Vihari, Wriddhiman Saha, Ravi Ashwin, Umesh Yadav, Mohammed Shami, Jasprit Bumrah

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less